Login / Signup

Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.

Sarah E ConwayShrishti SaxenaClare Baecher-AllanRajesh KrishnanMaria K HoutchensBonnie I GlanzTaylor J SaracenoMariann Polgar-TurcsanyiGauruv BoseRohit BakshiShamik BhattacharyyaKristin GalettaTamara KaplanChristopher SeversonTarun SinghalLynn StazzoneJonathan ZurawskiAnu PaulHoward L WeinerBrian C HealyTanuja Chitinis
Published in: Multiple sclerosis journal - experimental, translational and clinical (2023)
NCT05060354.
Keyphrases
  • sars cov
  • multiple sclerosis
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • ms ms
  • patient reported outcomes
  • coronavirus disease